Insider track record
OtherNot enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the full record of transactions filed by Hewes L. Becker. Insider active across 2 companies, notably Blueprint Medicines Corp. In total, 20 reports have been logged. Split: 0 buy · 9 sells. Total volume traded: €1.4m. History available since 2 June 2021. The latest transaction was filed on 5 January 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Hewes L. Becker
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
264,629 shares0Common StockSEC:0001193125-26-006723:0
21,353 sharesCommon StockSEC:0001104659-25-069391:0
4,863 shares@ US$88.8012.2% of flowCommon StockSEC:0001415889-25-007407:0
11,000 shares0Common StockSEC:0001415889-25-006611:0
2,424 shares@ US$104.917.0% of flowCommon StockSEC:0001415889-24-015734:0
10,573 shares@ US$66.2419.3% of flowCommon StockSEC:0001415889-24-015315:0
3,097 shares@ US$90.697.7% of flowCommon StockSEC:0001415889-24-007562:0
12,500 shares0Common StockSEC:0001415889-24-007015:0
1,404 shares@ US$52.052.0% of flowCommon StockSEC:0001415889-23-009402:0
1,466 shares@ US$45.721.9% of flowCommon StockSEC:0001415889-23-004563:0
12,500 shares0Common StockSEC:0001415889-23-004265:0
1,220 shares@ US$59.762.6% of flowCommon StockSEC:0001415889-22-006307:0
2,219 shares@ US$60.004.6% of flowCommon StockSEC:0001415889-22-003186:0
1,047 shares@ US$56.192.1% of flowCommon StockSEC:0001415889-22-002734:0
8,750 shares0Common StockSEC:0001415889-22-002439:0
729 shares@ US$66.241.6% of flowCommon StockSEC:0001179110-21-011105:0
729 shares@ US$66.241.6% of flowCommon StockSEC:0001179110-21-010209:0
729 shares@ US$66.241.6% of flowCommon StockSEC:0001179110-21-009515:0
8,750 shares@ US$66.2418.6% of flowCommon StockSEC:0001179110-21-008827:0
1,292 shares@ US$89.033.6% of flowCommon StockSEC:0001179110-21-008826:0
About Hewes L. Becker
Hewes L. Becker is a declarant with 20 filings in total. Among the 20 sampled recent filings, they relate to disposals, with EUR 0 of purchases and EUR 1,366,909 of sales between 2021-09-17 and 2026-01-07. The filings concern Blueprint Medicines Corp, where the person is Chief Medical Officer, and Galecto, Inc., where the person is also Chief Medical Officer.